glp 1 osteoarthritis The potential role of GLP‐1 receptor agonists in - Ryan - 2025 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy Obesity is a major risk
Description
When weight loss occurs, the body may resist further weight loss by increasing hunger hormones, such as ghrelin, and reducing the production of satiety hormones
Cost was not considered in the recommendations
Analysis of suicide and self-injury cases reported to FAERS currently does not indicate any safety concerns directly attributable to GLP-1RA
Not just the drug itself but the delivery systems
Precision isnt optional
Patients using compounded versions from non-registered facilities may experience variable appetite suppression due to inconsistent formulations
